Toll-Like Receptor 3 Signaling Contributes to Regional Neutrophil Recruitment in Cultured Human Glomerular Endothelial Cells

被引:15
|
作者
Liu, Qiang [1 ,2 ]
Imaizumi, Tadaatsu [3 ]
Kawaguchi, Shogo [4 ]
Aizawa, Tomomi [5 ]
Matsumiya, Tomoh [3 ]
Watanabe, Shojiro [5 ]
Tsugawa, Koji [5 ]
Yoshida, Hidemi [3 ]
Tsuruga, Kazushi [5 ]
Joh, Kensuke [6 ]
Kijima, Hiroshi [1 ]
Tanaka, Hiroshi [1 ,7 ]
机构
[1] Hirosaki Univ, Dept Pathol & Biosci, Grad Sch Med, Hirosaki, Aomori, Japan
[2] China Med Univ, Dept Nephrol, Hosp 1, Shenyang, Liaoning, Peoples R China
[3] Hirosaki Univ, Dept Vasc Biol, Grad Sch Med, Hirosaki, Aomori, Japan
[4] Hirosaki Univ, Dept Gastroenterol, Grad Sch Med, Hirosaki, Aomori, Japan
[5] Hirosaki Univ Hosp, Dept Pediat, Hirosaki, Aomori, Japan
[6] Tohoku Univ, Dept Pathol, Grad Sch Med, Sendai, Miyagi, Japan
[7] Hirosaki Univ, Dept Sch Hlth Sci, Fac Educ, Hirosaki, Aomori 0368560, Japan
关键词
CXCL1; E-selectin; Human glomerular endothelial cells; Neutrophil recruitment; Purpura nephritis; Toll-like receptor 3; DOUBLE-STRANDED-RNA; ADHESION MOLECULES; EXPRESSION; ACID; ASSOCIATION; LESIONS; CXCL1;
D O I
10.1159/000489507
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Given the importance of neutrophil recruitment in the pathogenesis of glomerulonephritis (GN), the representative neutrophil chemoattractant C-X-C motif chemokine 1 (CXCL1)/GROa and the adhesion molecule E-selectin in glomerular endothelial cells (GECs) play a pivotal role in the development of GN. Endothelial Toll-like receptor 3 (TLR3) is thought to be involved in the inflammatory response via innate immunity. However, the role of endothelial TLR3 signaling in the expression of neutrophil chemoattractants and adhesion molecules remains to be elucidated. Thus, we aimed to examine this issue. Methods: We treated normal human GECs with polyinosinic-polycytidylic acid (poly IC), an authen-tic double-stranded RNA, and analyzed the expressions of CXCL1 and E-selectin using quantitative real-time reverse transcription-polymerase chain reaction, western blotting, and enzyme-linked immunosorbent assay. To further elucidate the poly IC-induced signaling pathway, we subjected the cells to RNA interference against TLR3, interferon (IFN)-beta, nuclear factor (NF)-kappa B p65, and IFN regulatory factor (IRF) 3. We also used immunofluorescence to examine the endothelial expression of CXCL1 in biopsy specimens from patients with crescentic and non-crescentic purpura nephritis (PN). Results: We found that the activation of TLR3 induced the endothelial expression of CXCL1 and E-selectin, and that this involved TLR3, -NF-kappa B, IRF3, and IFN-beta. Intense endothelial CXCL1 expression was observed in biopsy specimens from patients with crescentic PN. Conclusion: These findings support a role for glomerular antiviral innate immunity in the pathogenesis of GN. Intervention of glomerular TLR3 signaling may therefore be a suitable therapeutic strategy for treating GN in the future. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:349 / 358
页数:10
相关论文
共 50 条
  • [41] MicroRNAs activate natural killer cells through Toll-like receptor signaling
    He, Shun
    Chu, Jianhong
    Wu, Lai-Chu
    Mao, Hsiaoyin
    Peng, Yong
    Alvarez-Breckenridge, Christopher A.
    Hughes, Tiffany
    Wei, Min
    Zhang, Jianying
    Yuan, Shunzong
    Sandhu, Sumeet
    Vasu, Sumithira
    Benson, Don M., Jr.
    Hofmeister, Craig C.
    He, Xiaoming
    Ghoshal, Kalpana
    Devine, Steven M.
    Caligiuri, Michael A.
    Yu, Jianhua
    BLOOD, 2013, 121 (23) : 4663 - 4671
  • [42] Sphingomyelin Phosphodiesterase Acid-Like 3b is Essential for Toll-Like Receptor 3 Signaling in Human Podocytes
    Watanabe, Shojiro
    Hidenori, Umetsu
    Hashimoto, Shun
    Riko, Sato
    Aizawa, Tomomi
    Tsugawa, Koji
    Imaizumi, Tadaatsu
    Tanaka, Hiroshi
    JOURNAL OF MEMBRANE BIOLOGY, 2022, 255 (01): : 117 - 122
  • [43] Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors
    Shime, Hiroaki
    Matsumoto, Misako
    Oshiumi, Hiroyuki
    Tanaka, Shinya
    Nakane, Akio
    Iwakura, Yoichiro
    Tahara, Hideaki
    Inoue, Norimitsu
    Seya, Tsukasa
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (06) : 2066 - 2071
  • [44] Toll-like receptor 4 orchestrates neutrophil recruitment into airways during the first hours of Bordetella pertussis infection
    Moreno, Griselda
    Errea, Agustina
    Van Maele, Laurye
    Roberts, Roy
    Leger, Helene
    Sirard, Jean Claude
    Benecke, Arndt
    Rumbo, Martin
    Hozbor, Daniela
    MICROBES AND INFECTION, 2013, 15 (10-11) : 708 - 718
  • [46] Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling
    Garcia-Cattaneo, Alejandra
    Gobert, Francois-Xavier
    Mueller, Melanie
    Toscano, Florent
    Flores, Marcella
    Lescure, Aurianne
    Del Nery, Elaine
    Benaroch, Philippe
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (23) : 9053 - 9058
  • [47] Toll-Like Receptor 9 Signaling Delays Neutrophil Apoptosis by Increasing Transcription of Mcl-1
    El Kebir, Driss
    Damlaj, Anas
    Filep, Janos G.
    PLOS ONE, 2014, 9 (01):
  • [48] Human endogenous RNAs: Implications for the immunomodulation of Toll-like receptor 3
    Amarante, Marla Karine
    Maeda Oda, Julie Massayo
    Vissoci Reiche, Edna Maria
    Morimoto, Helena Kaminami
    Aoki, Mateus Nobrega
    Ehara Watanabe, Maria Angelica
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (05) : 925 - 929
  • [49] Toll-like receptor 3 expressed by melanoma cells as a target for therapy?
    Salaun, Bruno
    Lebecque, Serge
    Matikainen, Sampsa
    Rimoldi, Donata
    Romero, Pedro
    CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4565 - 4574
  • [50] Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine
    Wolska, Anna
    Cebula-Obrzut, Barbara
    Smolewski, Piotr
    Robak, Tadeusz
    LEUKEMIA & LYMPHOMA, 2013, 54 (06) : 1268 - 1278